Clinical Trials List
2024-02-01 - 2026-04-30
Phase I
Terminated5
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/16
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu 無
- Chih-Chieh Yen 無
- 劉奕廷 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 姜乃榕 無
- San-Chi Chen 無
- Yi-Ping Hung 無
- Chien-An Liu 無
- 陳宥任 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 呂嘉偉 無
- 張境夫 無
- Chan-Keng Yang 無
- 吳教恩 無
- Hung-Chih Hsu 無
- 黃振洋 無
- 余紹銘 無
- 黃文冠 無
- Wen-Chi Chou 無
- Mengting Peng 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jeng-Shiun Du 無
- Tsung-Jang Yeh 無
- I-CHEN WU 無
- Wang Yao-Kuang 無
- Yi-Hsun Chen 無
- Hui-Ching Wang 無
- 高育青 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
81 participants
